On Demand: Current Treatment Strategies

At the conclusion of this program, the participant will be able to:

1. Apply recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypercholesterolemia, chronic coronary disease, and peripheral arterial disease.,

2. Apply the treatment approaches recommended in the 2018 ACC-AHA cholesterol guideline to patients with hypercholesterolemia.

3. Interpret recommendations from the ACC Expert Consensus Decision Pathway for nonstatins and treatment of hypertriglyceridemia.

4. Interpret the evidence and role in therapy of nonstatin medications in the treatment of hypercholesterolemia.

5. Demonstrate the evidence and guideline recommendations supporting the use of antiplatelet and antithrombotic therapy for secondary prevention patients.

6. Evaluate evidence-based drug therapy recommendations for the management of patients with chronic coronary disease and peripheral arterial disease.

7. Evaluate the role of colchicine in the prevention of CV events.

8. Create treatment plans that reduce the risk of cardiovascular disease.Description text goes here

Honing in on Herbal Remedies: Review of Commonly Used Agents

1. Describe the FDA regulatory framework for determining safety, efficacy, and labeling of herbal products.

2. Identify common herbal supplements and their potential therapeutic uses, as well as their associated adverse effects and various interactions with prescription or other over-the-counter medications.

3. Evaluate the safety and effectiveness of herbal supplements using evidence-based resources and patient-specific factors within example cases

Overcoming Obesity: Update on Current and Future Pharmacotherapy Options

4. Describe appropriate patients who may benefit from obesity pharmacotherapy.

5. Evaluate common obesity medications with potential therapeutic uses as well as common and severe adverse reactions

6. Identify potential future obesity medication therapies that may offer advantages over current FDA-approved agents

At the conclusion of this program, the participant will be able to:  

1. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension.

2. Review lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease .

3. Summarize how future cardiovascular risk is estimated in primary prevention patients using the Pooled Cohort Equations and PREVENT calculator.

4. Formulate a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement.

5. Illustrate emerging pharmacotherapies for the treatment of hypertension.

6. Analyze guideline recommendations supporting the use of antiplatelet therapy for primary prevention patients.

7. Examine the evidence-based CV risk reduction benefits of medications used to treat overweight and obese patients. 8

8. Create treatment plans that reduce the risk of cardiovascular disease.